Ball Jack 4
4 · Cytek Biosciences, Inc. · Filed Nov 30, 2022
Insider Transaction Report
Form 4
Ball Jack
Director
Transactions
- Exercise/Conversion
Common Stock
2022-11-29$0.92/sh+13,333$12,266→ 26,999 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-29−10,666→ 0 totalExercise: $0.40From: 2020-10-12Exp: 2028-10-12→ Common Stock (10,666 underlying) - Exercise/Conversion
Common Stock
2022-11-29$0.40/sh+10,666$4,266→ 13,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-29−13,333→ 0 totalExercise: $0.92Exp: 2030-07-24→ Common Stock (13,333 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/12th of the shares subject to the option shall vest monthly over one year from July 24, 2020.